Telaprevir + ritonavir in fed male volunteers

Trial Profile

Telaprevir + ritonavir in fed male volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Mar 2011

At a glance

  • Drugs Ritonavir; Telaprevir
  • Indications Hepatitis C; HIV infections
  • Focus Pharmacokinetics
  • Sponsors Janssen Infectious Diseases BVBA; Vertex Pharmaceuticals
  • Most Recent Events

    • 16 Mar 2011 New trial record
    • 02 Mar 2011 Results presented at the 18th Conference on Retroviruses and Opportunistic Infections.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top